Insecticides (India) Ltd Charts Long-Term Growth On Premiumization, New Launches & Global Strategy
By Ankur Chandra | Published at: Jun 3, 2025 03:05 PM IST
New Delhi, June 3, 2025 – Insecticides (India) Ltd (BSE: 532851, NSE: INSECTICID) has laid out a clear, bullish roadmap for FY26 and beyond, banking on premiumization, aggressive product launches, manufacturing expansion, and an emerging global footprint to drive sustained growth.
Strategic Outlook: Building on FY25 Momentum
After reporting a robust 32% YoY topline growth in Q4 FY25 and a 2% full-year revenue rise amid price pressures, the company is now doubling down on strategic levers to fuel a stronger FY26. Volume growth stood at 10% for FY25, while EBITDA margins expanded by 281 bps to reach 11.1%, with PAT margins rising to 7%.
MD Rajesh Kumar Aggarwal emphasized:
“We will continue our double-digit topline growth strategy, led by our premium Maharatna product portfolio and new launches. IIL is aiming to beat the industry average.”
Key Growth Drivers for FY26 & Beyond
Premium Product Focus & Launch Pipeline
- FY25 saw a record 12 new product launches, of which 4 were elevated to ‘Focused Maharatna’ status, now totaling 16 high-potential products.
- In FY26, 6 new launchesare lined up, including:
- Altair, a patented rice herbicide from Japanese partner Nissan.
- Other new introductions include Centran SC, Brahmos, Victor Gold, Sparkle, and more.
- The company is rapidly expanding its specialty herbicide portfolio, covering all major crops like rice, soybean, pulses, cotton, maize, and sugarcane.
Strong Technical & R&D Capabilities
- In-house technical production has scaled up with products like Terrox, Torry Super, Stroke, and Million now being manufactured from IIL’s own facilities.
- A team of 150+ R&D scientists is driving development across technicals, formulations, and international data submissions.
Manufacturing Capacity Expansion
- Dahej Plant: ₹150 crore capex completed; commercial production starts June 2025.
- Expected to contribute ₹100 crore revenue in FY26.
- Herbicide and insecticide capacities to be segregated between new and existing units.
- Sotanala Plant (Rajasthan): ₹100 crore capex planned for a fully automated facility, bolstering future growth from FY27 onward.
Global Market Strategy
- Current export contribution: ~5%, with plans to expand via:
- New registrations in the US, Europe, Japan, and South America.
- Strategic alliances like the JV with OAT Agro (Japan) now progressing toward commercializing the first New Chemical Entity (NCE).
Aggarwal noted:
“India is poised to be a key ‘China plus one’ partner globally. With regulatory approvals in place, we expect exports to grow gradually from FY26 onwards.”
Financial Discipline & Operational Focus
The company is actively managing its working capital and inventory buildup, which spiked in March 2025 to prepare for an anticipated strong kharif season.
Key Financial Projections & Targets
| Metric | FY25 | FY26 Guidance |
|---|---|---|
| Volume Growth | 10% | Double-digit expected |
| EBITDA Margin | 11.1% | +200–300 bps over 2–3 years |
| PAT | ₹142 Cr (up from ₹102 Cr) | Growth expected |
| ROCE | 18% | To improve |
| ROE | 13% | To improve |
Aggarwal added:
“We’re not chasing unrealistic targets. The focus is clear, stabilize margins, expand market share, and deliver value through innovation and execution.”
Conclusion: Primed for the Next Growth Phase
Insecticides India is strategically positioned to outperform in FY26 and sustain its momentum over the next three years with its diversified crop solutions, a sharp shift toward high-value patented products, and fresh manufacturing muscle. Investors and stakeholders can expect steady improvement in margins, new market entries, and a deeper presence in high-growth domestic and global segments.
REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/2863d994-5981-4d76-967f-9ed2be0c9cc1.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. Every effort is made to ensure the accuracy, relevance, and timeliness of the information provided. However, inadvertent errors or omissions may occasionally occur.
Should you have any concerns, queries, or wish to point out any discrepancies in our content, please write to us at content@hdfcsec.com. Your feedback is valuable and helps us maintain the highest standards of content integrity.
Please note that the information shared is intended solely for informational purposes and should not be construed as investment advice. Users are advised to consult their financial advisors before making any investment decisions.
